Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYGEN.L Regulatory News (YGEN)

  • There is currently no data for YGEN

Milestone Achieved

4 Jan 2007 07:00

ViaLogy PLC04 January 2007 ViaLogy plc ("ViaLogy" or "the Company") Milestone Achieved Completion of Key Milestone on Multi-parallax Exploitation ("MPEX") ElectronicEye(TM)Program with Boeing Phantom Works LONDON, Jan 2 -- ViaLogy plc (LSE: VIY), a leading innovator of real-timenetwork-centric signal processing platforms for sensor-intensive applications,announced today that it has successfully completed the Critical Design Review("CDR") Milestone on the Multi-parallax Exploitation ("MPEX") Electronic EyeTMProgram with Boeing Phantom Works ("Boeing") in Huntington Beach, CA, USA. The Electronic Eye(TM)program was initiated in direct response to emergingprecision detection requirements in next-generation missile detection anddefense systems (seekers) and panoramic airspace surveillance platforms. Underthe joint program with Boeing, ViaLogy's core signal processing technology -Quantum Resonance Interferometry ("QRI") - is providing the basic engine forpowering the silicon electronic-eye based on vision constructs found in insectsand reptiles. Vialogy has a patent pending on the MPEX Electronic Eye(TM)and itsapplications. Currently, most advanced vision systems are limited to only stereo vision with asingle parallax based on the co-registration of frames from two eyes, allowingonly a scan of the horizon. In contrast, MPEX Electronic Eye(TM)is exploitingmultiple parallaxes to achieve panoramic or 360-degree viewing capability andthree dimensional perception using multiple, overlapping fields-of-view. Thisconstruction dramatically increases the probability of target detection andlocalization. Dr. Edward McCullough, Principal Scientist in advanced aero analysis at BoeingPhantom Works, commented: "I am very excited by ViaLogy's rapid progress andnovel approach on the MPEX Electronic Eye(TM) Researchers have been studying thecomputational architectures, functions, mechanisms, and principles of visualperception underlying biological systems for over three decades to find ways toimplement them. We have specific near-term and long-term interests in thistechnology to support our defense, homeland security and space program needs." ViaLogy's Chief Technology Officer, Dr. Sandeep Gulati said: "We are buildingupon seminal work conducted by Dr. McCullough and his team in the area ofbiomimetic-based advanced autonomy for future planetary rovers and spaceoperations. Our core technology provides a near-term opportunity for overcomingsome of the fundamental information processing and system engineering challengesin implementing multi-parallax construction to address practicalomni-directional surveillance applications. MPEX has been developed as aplatform technology in its own right and we are now making good progress inadapting it for specific applications." ViaLogy's initial MPEX Electronic Eye(TM)applications are geared to detection ofvery fast moving targets such as in missile interceptors, deployment on fastmoving ground vehicles and airborne platforms such as UAVs (unmanned aerialvehicles), and omni-directional tower mounts for border surveillance andcritical infrastructure security. Commenting on the achievement of this milestone, ViaLogy's CEO, Michael Kelly,said: "MPEX is very well aligned with the ViaLogy business model. We can applyour unique expertise and sensor-agnostic signal processing technology tocommercial off-the-shelf hardware and sensors to deliver enhanced performance ata fraction of the cost of comparable systems especially designed for militaryapplications." Next steps in the Boeing collaboration include a demonstration of the use ofMPEX Electronic Eye(TM)engineering for detection of ground-based border intrusionevents, and an aerial payload for low altitude UAVs. Successful operationaldemonstration of the proprietary MPEX technology could lead to its use in anumber of future defense and homeland security programs. For further information please contact: ViaLogyMichael Kelly, CEO - US +1 626 296 6337Terry Bond, Chairman - UK & Europe +44 (0)20 2869 7014 Redleaf CommunicationsEmma Kane / Samantha Robbins +44 (0)20 7822 0200 About ViaLogy: Network Centric Signal Processing. ViaLogy is a leading innovator of network-centric, real-time signal processingplatforms for sensor (intensive) applications. ViaLogy is currently deployingand designing computational systems, powered by its patented technologies, forapplications in life sciences, public safety and security, surveillance, defenseand geoseismology. Vialogy focuses on market driven problems where automation,timeliness, quality and reliability of information processing are essential.ViaLogy's core competency incorporates rapidly and accurately detecting weaksignals buried in high noise background and clutter. This technology can beemployed to solve problems involving sensor integration and information overloadchallenges involving video, telephony and control sensors, as well as forenhancement of numerous signal processing applications. For more information,visit our website at www.vialogy.com. Except for statements of historical fact, the information presented hereinconstitutes forward-looking statements within the meaning of the PrivateSecurities Litigation Reform Act of 1995. Such forward-looking statementsinvolve known and unknown risks, uncertainties and other factors which may causethe actual results, performance or achievements of the company to be materiallydifferent from any future results, performance or achievements expressed orimplied by such forward-looking statements. Such factors include generaleconomic and business conditions, the ability to acquire and develop specificprojects, the ability to fund operations and changes in consumer and businessconsumption habits and other factors over which ViaLogy has little or nocontrol. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
15th Apr 201412:30 pmRNSSuspension
9th Apr 20141:55 pmRNSChange of Advisers and Registered Office
26th Mar 20143:16 pmRNSCompletion of VEC Transfer
21st Mar 20147:00 amRNSResignation of Dr. Robert Dean
19th Mar 20143:09 pmRNSReplacement announcement: Grant of options
19th Mar 201412:25 pmRNSGrant of options
7th Mar 20141:43 pmRNSHolding(s) in Company
7th Mar 20141:39 pmRNSHolding(s) in Company
27th Jan 20142:00 pmRNSResult of General Meeting
24th Jan 20143:22 pmRNSResult of Open Offer
7th Jan 20147:00 amRNSPlacing, Open Offer & Notice of General Meeting
4th Dec 20134:13 pmRNSResult of General Meeting
2nd Dec 20138:00 amRNSHalf Yearly Report
18th Nov 20131:30 pmRNSNotice of General Meeting & Proposed Board Changes
29th Oct 20133:31 pmRNSResult of AGM
29th Oct 20137:00 amRNSRestructure Proposals
30th Sep 20137:00 amRNSFinal Results
29th Aug 20139:00 amRNSNotice of AGM
19th Jun 20133:09 pmRNSExercise of Warrants & TVR
8th May 20137:00 amRNSContract Win
29th Apr 20137:00 amRNSBusiness & Technical Collaboration with CGG
16th Apr 20137:00 amRNSChange of Adviser
12th Apr 20137:00 amRNSChevron - precision subsurface mapping contract
8th Feb 20133:01 pmRNSPlacing of £1.4 million
7th Jan 20137:00 amRNSFiling of QuantumRD patents in nine countries
2nd Jan 20138:36 amRNSChevron Expands ViaLogy Contract
31st Dec 20127:00 amRNSHalf Yearly Report
19th Dec 20127:00 amRNSCEO Overview
21st Nov 20127:00 amRNSMove into Shale Oil Development
16th Nov 20127:00 amRNSNorth Sea Project Underway
1st Oct 20127:00 amRNSQuantumRD Services in China
20th Sep 20127:00 amRNSPresentation at Singapore Conference
23rd Jul 20121:50 pmRNSResult of AGM
29th Jun 20127:00 amRNSFinal Results
15th Jun 201211:25 amRNSResult of General Meeting
23rd May 20127:00 amRNSNotice of General Meeting
21st May 20127:00 amRNSPlacing
11th May 20129:30 amRNSIssue of Equity - Options Exercise
10th May 20127:00 amRNSBusiness Update
2nd May 201212:24 pmRNSContract Award
23rd Apr 20127:00 amRNSContract win
16th Apr 20127:00 amRNSSuccessful Texas Oil Well Drilled
12th Apr 20127:00 amRNSContract Win
14th Mar 20127:00 amRNSQuantumRD demonstration to Chevron
18th Jan 20127:00 amRNSPlacing and TVR
3rd Jan 20127:00 amRNSBusiness Update
30th Dec 20117:00 amRNSInterim Report & Accounts
28th Oct 201112:36 pmRNSResult of AGM
11th Oct 20113:28 pmRNSPlacing & TVR
30th Sep 20117:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.